ZSZohre Sadeghian

Zohre Sadeghian

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Zohre Sadeghian has a total of 33 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Chronic Granulomatous Peritonitis From Recurrent Bilateral Ovarian Mature Cystic Teratomas Masquerade as Peritoneal Carcinomatosis

    by Zohre Sadeghian, Joel Cardenas, Kirill Lyapichev, Albert Parlade, Elvia Goez‐Gutierrez, Amir Behdad, Esther Yoon

    Although rare, ruptured mature cystic teratoma (MCT) can cause chronic granulomatous peritonitis that mimics peritoneal carcinomatosis. In patients with a history of cystectomy for MCT, careful clinicoradiologic and histopathologic correlation is essential to avoid misdiagnosis and unnecessary aggressive treatment.

  • Serial VAF Kinetics Reveal Dynamic Clonal Evolution Associated With Progression in Clonal Cytopenia of Undetermined Significance

    by Zohre Sadeghian, Mark Jinan Chen, Kirill A. Lyapichev, Chieh‐Lin Fu, Chakra Chaulagain, Maria Julia Diacovo, David S. Bosler, Amir Behdad

    Background: Clonal cytopenia of undetermined significance (CCUS) is a premalignant condition characterized by persistent cytopenias with somatic mutations but no morphologic evidence of overt myeloid neoplasia. While CCUS confers an elevated risk of progression to myeloid malignancies, the timing and biology of this transformation remain unpredictable. We hypothesized that the type of mutated gene and tracking clonal expansion over time via serial variant allele frequency (VAF) measurements may uncover early evolutionary signatures of malignant progression. Design: We retrospectively analyzed 55 CCUS patients who underwent serial next‐generation sequencing (NGS) testing. Patients were stratified by their final clinical course at the time of this study as non‐progressor ( n = 26) or progressor ( n = 29). Baseline clinicopathologic variables, mutation burden, and the presence of ≥ 1 high‐risk mutation, which was defined in prior studies as SF3B1 , SRSF2 , ZRSR2 , JAK2 , TP53 , RUNX1 , FLT3 , IDH1 , and IDH2 , were compared between groups. The maximum annualized VAF slope across all tracked mutations was used as the primary dynamic clonal expansion metric. Baseline risk was assessed using the Clonal Hematopoiesis Risk Score (CHRS), and maximum VAF slope was evaluated across CHRS categories to determine whether serial clonal kinetics provided additional prognostic value beyond baseline risk stratification. Results: Compared with non‐progressors, progressors had a higher baseline mutation burden ( p < 0.01), more frequently harbored ≥ 1 high‐risk mutation at baseline ( p < 0.01), and also more acquired new mutations during follow‐up ( p < 0.01). Across longitudinally tracked mutations, progressor‐associated clones more frequently demonstrated positive annualized VAF slopes, particularly involving RUNX1 (12.70%/year), STAG2 (13.09%/year), ASXL1 (6.44%/year), SRSF2 (4.29%/year), and U2AF1 (8.21%/year). Maximum annualized VAF slope correlated with CHRS risk category but also identified increased clonal expansion among progressors within the non‐high CHRS subgroup ( p = 0.006), suggesting added dynamic prognostic value beyond static baseline risk classification. Conclusion: Serial VAF kinetics are helpful in predicting progression and complement baseline clinicopathologic features and CHRS risk stratification in CCUS. Expanding VAF trajectories, particularly involving RUNX1 , spliceosome genes, and cohesin‐related genes, may reflect biologically active clonal evolution toward progression to myeloid neoplasm, whereas stable or declining VAFs were more often observed in stable CCUS. These findings support that longitudinal VAF monitoring could be a practical dynamic approach to identify patients who require closer surveillance or repeat marrow evaluation.

  • Open Access

    Utilization of Next-Generation Sequencing (NGS) in Unexplained Cytopenia

    by Zohre Sadeghian, Kirill A. Lyapichev, Mark J. Chen, Maria J. Diacovo, Chakra Chaulagain, Chieh-Lin Fu, David S. Bosler, Amir Behdad

  • Open Access

    Clinicopathologic and histologic determinants of the oncotype DX recurrence score in ER+/HER2− breast cancer: AJCC stage-matched comparisons and predictors of a very low recurrence score

    by Zohre Sadeghian, Sara Rhode, Hadi Sultan, Theresa Abdo, Ahmad Alhalabi, Elvia Goez-Gutierrez, Zeina Nahleh, Esther Yoon

  • Open Access

    Balamuthia mandrillaris amoebic encephalitis clinically mimicking myasthenia gravis exacerbation: a diagnostic challenge

    by Zohre Sadeghian, Richard Prayson, Fouad Abuzeid, Alma Reyes-Trocchia, Amir Behdad

    Balamuthia mandrillaris is a rare cause of granulomatous amoebic encephalitis (GAE) with a high mortality rate. Here, we describe the diagnostic challenges in a 70-year-old immunocompromised man with myasthenia gravis (MG). The patient presented with vision loss, diplopia, generalized weakness and respiratory compromise, initially attributed to MG exacerbation. Neuroimaging revealed multiple ring-enhancing brain lesions concerning for infection. A comprehensive cerebrospinal fluid (CSF) and serologic workup, including bacterial and fungal cultures, pan-viral PCR panel, toxoplasma PCR/serology, tuberculosis PCR and prion testing, did not reveal a causative pathogen. During the 5-day hospitalization, prophylactic trimethoprim-sulphamethoxazole (TMP-SMX) was initiated because of the patient’s long-term corticosteroid therapy and lymphopenia, to prevent P. jirovecii pneumonia. Despite persistent neurological symptoms, he remained haemodynamically stable, maintained respiratory function and showed improvement in strength with supportive therapy. He was discharged with close outpatient follow-up and continuing TMP-SMX. Five days later, he re-presented with fever and altered mental status. The imaging at this time shows the progression of intracranial lesions, and he underwent a brain biopsy which demonstrated chronic encephalitis with structures suspicious for amoebae, and finally, the reference laboratory PCR confirmed B. mandrillaris. The patient died the same day the diagnosis was established. This case highlights the difficulty of distinguishing GAE from MG relapse, the limited yield of CSF studies and the critical role of early brain biopsy and rapid PCR in diagnosing Balamuthia infection.

  • Open Access

    Balamuthia Mandrillaris Amoebic Encephalitis Clinically Mimicking as Myasthenia Gravis Exacerbation: A Diagnostic Challenge

    by Zohre Sadeghian, Richard Prayson, Fouad Abuzeid, Alma Reyes-Trocchia, Amir Behdad

    The case is a 70-year-old immunocompromised male with a history of myasthenia gravis (MG). He presented with new-onset, persistent diplopia and headache unresponsive to prior therapy, initially suspected to be a recurrent MG exacerbation, for which oral prednisone was added to his treatment. The patient's condition worsened over the 10-day period following the clinic visit, with ongoing vision loss, increasing weakness, and intermittent shortness of breath. During this period, he also experienced a transient episode of right-hand numbness, which resolved spontaneously. He was admitted for suspected recurrent MG; neurology raised concerns about an alternative underlying process and ordered a magnetic resonance imaging (MRI) scan, which revealed multiple ring-enhancing lesions highly suggestive of an intracranial infection. Empiric antibiotics were initiated, but an extensive infectious disease workup was inconclusive. He was discharged in stable condition, with a brain biopsy and follow-up MRI scheduled for further evaluation. Five days later, he returned to the emergency department with decreased level of consciousness, fever, and confusion. He underwent a brain biopsy, which revealed evidence of an amoebic infection. In the subsequent days, his condition deteriorated rapidly, and he passed away on the same day that a diagnosis of Balamuthia mandrillaris infection was confirmed via PCR on a brain tissue sample. This case highlights significant diagnostic challenge in MG patients, where rare infections can closely mimic disease flare-ups. As demonstrated in our case, failing to recognize infections can lead to severe consequences. In MG patients with worsening, treatment-resistant symptoms and atypical presentations, MRI is strongly recommended.

  • Open Access

    Balamuthia Mandrillaris Amoebic Encephalitis Clinically Mimicking as Myasthenia Gravis Exacerbation: A Diagnostic Challenge

    by Zohre Sadeghian, Richard Prayson, Fouad Abuzeid, Alma Reyes-Trocchia, Amir Behdad

    The case is a 70-year-old immunocompromised male with a history of myasthenia gravis (MG). He presented with new-onset, persistent diplopia and headache unresponsive to prior therapy, initially suspected to be a recurrent MG exacerbation, for which oral prednisone was added to his treatment. The patient's condition worsened over the 10-day period following the clinic visit, with ongoing vision loss, increasing weakness, and intermittent shortness of breath. During this period, he also experienced a transient episode of right-hand numbness, which resolved spontaneously. He was admitted for suspected recurrent MG; neurology raised concerns about an alternative underlying process and ordered a magnetic resonance imaging (MRI) scan, which revealed multiple ring-enhancing lesions highly suggestive of an intracranial infection. Empiric antibiotics were initiated, but an extensive infectious disease workup was inconclusive. He was discharged in stable condition, with a brain biopsy and follow-up MRI scheduled for further evaluation. Five days later, he returned to the emergency department with decreased level of consciousness, fever, and confusion. He underwent a brain biopsy, which revealed evidence of an amoebic infection. In the subsequent days, his condition deteriorated rapidly, and he passed away on the same day that a diagnosis of Balamuthia mandrillaris infection was confirmed via PCR on a brain tissue sample. This case highlights significant diagnostic challenge in MG patients, where rare infections can closely mimic disease flare-ups. As demonstrated in our case, failing to recognize infections can lead to severe consequences. In MG patients with worsening, treatment-resistant symptoms and atypical presentations, MRI is strongly recommended.

  • Open Access

    Cytological Assessment of Metastatic Gastrointestinal Stromal Tumor in Ascitic Fluid

    by Hadi Sultan, Zohre Sadeghian, Elvia Goez‐Gutierrez, M. Julia Diacovo, Esther Yoon

    Gastrointestinal stromal tumors (GISTs) are mesenchymal neoplasms typically arising in the stomach and small intestine and rarely involving extra‐gastrointestinal organs. While fine‐needle aspiration (FNA) offers reliable diagnosis, exfoliation of GIST cells into body fluids is exceedingly rare and diagnostically challenging. We report a case of a 69‐year‐old male with metastatic GIST in ascitic fluid. The cells revealed atypical epithelioid morphology with high nuclear‐to‐cytoplasmic ratio and nuclear irregularities. Immunohistochemistry (IHC) demonstrated positivity for CD117 and DOG1. Diagnosis requires integration of clinical history, cytomorphology, and a broad IHC panel. Awareness of its cytologic features, application of mesenchymal markers, and molecular testing are critical for accurate diagnosis and effective clinical management.

  • Ameliorating Paraquat-Induced Nephrotoxicity in Rats: Protective Effects of Nanocurcumin on Renal Histology and Molecular Pathways

    by Davood Ahmadi Moghaddam, Mehdi Rahimi, Nejat Kheiripour, Zohre Sadeghian, Sara Soleymani Asl, Zahra Azizi, Akram Ranjbar

    Background: Paraquat (PQ) is a common herbicide, and its mortality results from injury to several organs, including the kidneys. Nanocurcumin and curcumin have anti-inflammatory and anti-oxidative activities, but their involvement in PQ-induced kidney damage is unclear. Therefore, the goal of our study was to compare nanocurcumin and curcumin in male rats whose kidneys were damaged by PQ. Method: 42 eight-week male albino Wistar rats were put into six groups at random as control, control + curcumin, control + nanocurcumin, PQ, PQ + curcumin, PQ + nanocurcumin for 7 days. The kidney tissues and serum were collected at the end of this period. Total antioxidant capacity (TAC), lipid peroxidation (LPO), total thiol Molecule (TTM), urea, creatinine, and blood urea nitrogen (BUN) levels were assessed. The histopathological evaluation of kidney damage was performed at the end of our study. Moreover, the gene expression was assessed by biochemical and Reverse transcription polymerase chain reaction (RT-PCR) analysis. Result: Curcumin and nanocurcumin administration alleviated PQ-induced renal injury, as evidenced by reduced serum creatinine and BUN levels. The levels of antioxidant markers, like TAC and TTM, increased and decreased the levels of oxidative stress indexes like LPO. Furthermore, our result shows up-regulating the expression of nuclear factor-like 2 (Nrf2), NAD (P) H: quinine oxidoreductase 1 (NQO1), Heme oxygenase 1 (HO-1), and down-regulating the expression of Kelchlike ECH-associated protein 1 (Keap-1) in renal tissue. Conclusion: Niosomal curcumin was more advantageous than ordinary curcumin in lowering oxidative stress and renal tissue damage induced by paraquat intoxication.

  • Open Access

    Clinicopathological insights into an outbreak of foodborne botulism in Hamadan, Iran, in 2023: A microbiological and laboratory findings

    by Zohre Sadeghian, Fatemeh Torkaman Asadi

    Background and Objective: Foodborne botulism is one of the potentially fatal forms of food poisoning, usually caused by ingestion of home-canned vegetables, fruits, and dairy and fish products. This study aimed to assess the frequency of signs and symptoms in patients with botulism following the ingestion of homemade Doogh, a traditional milk-based beverage, in Hamadan, Iran in 2023. We also examined the general characteristics of the recruited patients. Methods: During an outbreak, 21 patients were referred to the hospital because of food poisoning. All patients had a history of consumption of Doogh. After careful physical examination, all of them were hospitalized. Botulism was suspected in all patients except for the first patient. Results: The mean age of admitted patients was 33.09 ± 18.44 years, with 23.80% being males and 76.20% females. Incubation period in our patients was 68 ± 28.48 h. Notable symptoms included diplopia (95.23%), nausea and vomiting (85.71%), blurred vision (80.95%), and dizziness (61.90%). The laboratory results were within the normal range. No deaths occurred in this patient cohort. Furthermore, botulinum spores were detected in Doogh samples collected from the outbreak, confirming the presence of Clostridium botulinum spores as a source of the outbreak. Conclusions: This study highlights that the initial manifestations of botulism predominantly involved ophthalmologic abnormalities in most patients. Additionally, symptoms such as nausea, vomiting, and dizziness may manifest in cases of foodborne botulism. Timely diagnosis and treatment of botulism following the consumption of homemade Doogh played a crucial role in achieving positive outcomes, with no fatalities recorded in this patient cohort.